- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01851655
Anterior Cruciate Ligament Reconstruction and Plyometric Exercise
The Effect of Plyometric Exercise Intensity on Function & Articular Cartilage Metabolism After ACL Reconstruction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As part of the study, investigators will insure patients meet the criteria for advanced rehabilitation based on knee motion, pain levels and quadriceps strength.
Participants will be asked to review the informed consent and consent to the study prior to any study procedures. The study will consist of 2 testing sessions and an 8 week intervention (2 visits per week) at the UF&Shands Orthopaedics and Sports Medicine Institute. The testing sessions will include clinical measures of knee impairments, questionnaires, biomechanical analysis and functional performance testing.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32607
- UF&Shands Orthopaedics and Sports Medicine Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- time from injury to ACL reconstruction is no greater than 6 months,
- pre-injury activity level includes participation in high-demand activities, and
- meet the criteria for advanced rehabilitation including full active knee extension, active knee flexion within 5 degrees of the contralateral side, pain rating no greater or equal to 1/10 with activities of daily living, and involved side knee extensor strength at least 60% of the contralateral side.
Exclusion Criteria:
- bilateral knee injury,
- prior knee ligament injury and/or surgery,
- concomitant other ligamentous injury > Grade I,
- meniscal repair performed in conjunction with ACL reconstruction,
- cartilage repair procedure performed in conjunction with ACL reconstruction,
- complications during surgery requiring protocol modification, and
- renal disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Plyometric Exercise - High intensity
The exercises should produce a higher peak vertical ground reaction force than those in the low group based on literature findings (e.g.
single leg jumps, jumps from higher heights, higher percent effort).
|
Treatment sessions include a combination of running, jumping and agility activities (plyometric exercise).
Each rehabilitation session will also include an abbreviated, standardized program of lower extremity strengthening (leg press, machine squats, knee extensions; 3 sets x 10 repetitions each), flexibility (standing gastrocnemius and quadriceps stretch, hamstrings stretch in long-sitting; 2 x 30 seconds each) and proprioception (standing on foam and a tilt board; 3 x 30 seconds each).
|
|
ACTIVE_COMPARATOR: Plyometric Exercise - Low intensity
A lower peak vertical ground reaction force will be generated in the low intensity group compared to the high intensity group based on findings in the literature (e.g.
lower box heights, only two-legged jumps, lower percent effort)
|
Treatment sessions include a combination of running, jumping and agility activities (plyometric exercise).
Each rehabilitation session will also include an abbreviated, standardized program of lower extremity strengthening (leg press, machine squats, knee extensions; 3 sets x 10 repetitions each), flexibility (standing gastrocnemius and quadriceps stretch, hamstrings stretch in long-sitting; 2 x 30 seconds each) and proprioception (standing on foam and a tilt board; 3 x 30 seconds each).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in International Knee Documentation Committee (IKDC) Subjective Form Score.
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
The IKDC subjective form is a measure of self-reported knee function.
It includes items related to symptoms and functional activities.
Scores range from 0 to 100 points, and higher scores equal higher function.
Responses will be recorded on hard-copy and entered into a spreadsheet to calculate the score.
The change will be computed as (post-intervention score minus pre-intervention score).
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
|
Change in Urinary Concentrations of the C-terminal Crosslinking Telopeptide of Type II Collagen (CTX-II)
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
CTX-II is a biomarker of Type II collagen degradation.
Early morning, second-void urine samples will be collected and stored.
Concentrations of CTX-II will be determined with enzyme-linked immunosorbent assay and corrected for creatinine concentration, which will also be determined with enzyme-linked immunosorbent assay.
Values will be log-transformed.
The change in urinary CTX-II concentration will be computed as (post-intervention value minus pre-intervention value).
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Vertical Jump Height.
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
Vertical jump height will be assessed with the Vertex.
The average of three trials will be recorded in cm.
The change in vertical jump height will be computed as (post-intervention value minus pre-intervention value).
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
|
Change in the Ratio of Urinary CTXII to Serum CPII Concentrations.
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
CTX-II is a biomarker of Type II articular cartilage degradation.
Type II collagen carboxy propeptide (CPII) is a biomarker of Type II collagen synthesis.
Early morning urine and blood samples will be collected pre- and post-treatment.
Urinary CTX-II will be analyzed as described in Primary Outcomes.
Serum CPII will be determined using enzyme-linked immunosorbent assay.
Values of both biomarkers will be log-transformed, and the ratio of CTXII:CPII will be calculated.
The change will be computed as (post-intervention CTXII:CPII values minus pre-intervention CTXII:CPII value).
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quadriceps Strength
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
Knee extensor torque will be measured with an isokinetic dynamometer.
The lever arm will move at 60 degrees/second.
The peak torque from 5 trials will be obtained and normalized to body weight.
The change will be computed as (post-intervention value minus pre-intervention value)
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
|
Change in Fear of Movement/Re-injury
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
The 11-item version of the Tampa Scale for Kinesiophobia will be used to assess kinesiophobia or fear of movement/re-injury.
Scores range from 11 to 44 points, and higher scores equal higher fear of movement/re-injury.
Responses will be recorded on hard-copy and entered into a spreadsheet to calculate the score.
The change will be computed as (post-intervention score minus pre-intervention score).
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
|
Change in Anterior Knee Laxity
Time Frame: Baseline (pre-intervention) to 9 weeks (post-intervention)
|
Anterior knee laxity will be assessed with a knee arthrometer and a maximum manual pull.
The side-to-side difference will be recorded in mm.
The change will be computed as (post-intervention difference minus pre-intervention difference).
|
Baseline (pre-intervention) to 9 weeks (post-intervention)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Terese L Chmielewski, PT, PhD, University of Florida
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 156-2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Reconstruction
-
Federal University of Health Science of Porto AlegreRecruitingAnterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament Reconstruction RehabilitationBrazil
-
Federal University of Health Science of Porto AlegreRecruitingAnterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament Reconstruction RehabilitationBrazil
-
Egas Moniz - Cooperativa de Ensino Superior, CRLRecruitingAnterior Cruciate Ligament Reconstruction | Athlete | Anterior Cruciate Ligament Reconstruction RehabilitationPortugal
-
Hacettepe UniversityRecruitingAnterior Cruciate Ligament Reconstruction Rehabilitation | Strength Outcomes | Anterior Cruciate Ligament (ACL) Reconstruction SurgeryTurkey (Türkiye)
-
University of Sao Paulo General HospitalUnknownAnterior Cruciate Ligament Reconstruction | Rehabilitation | Anterolateral Ligament ReconstructionBrazil
-
Hospital for Special Surgery, New YorkRecruitingAnterior Cruciate Ligament Reconstruction | Medial Patellofemoral Ligament ReconstructionUnited States
-
Universiti Sains MalaysiaNot yet recruitingAnterior Cruciate Ligament ReconstructionChina
-
Marquette UniversityRecruitingAnterior Cruciate Ligament ReconstructionUnited States
-
Assaf-Harofeh Medical CenterRecruitingAnterior Cruciate Ligament ReconstructionIsrael
-
Linnaeus UniversityNot yet recruitingAnterior Cruciate Ligament ReconstructionSweden
Clinical Trials on Plyometric Exercise
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Universidad Católica San Antonio de MurciaActive, not recruitingPlyometric ExercisesSpain
-
Universidad Europea de MadridCompletedHealthy PopulationSpain
-
Cairo UniversityNot yet recruitingLower Limb Burn | Lower Limb FunctionEgypt
-
University of Missouri-ColumbiaCompletedOsteoporosis | Osteopenia
-
Cairo UniversityPrince Sattam Bin Abdulaziz UniversityCompletedCerebral PalsySaudi Arabia
-
University of VigoNot yet recruitingBreast Cancer | Breast Cancer Survivor | Breast Cancer Patients | Breast Cancer - FemaleSpain
-
University of FloridaRecruitingShoulder Pain | Healthy AdultUnited States
-
Riphah International UniversityCompletedSports Physical Therapy | Sports InjuryPakistan
-
Cairo UniversityNot yet recruitingChronic Kidney DiseasesEgypt